I think that the mRNA vaccines success will lead to a huge influx of universities/investors sponsoring mRNA research and techniques since they see it as somethi

I think that the mRNA vaccines success will lead to a huge influx of universities/investors sponsoring mRNA research and techniques since they see it as something viable now(possibly initially a negative if it means less sharing). Now combine that with decreasing DNA sequencing costs, it should put us on a path where the feasibility of cancer sequencing as a standard method of _exact_ identification and mRNA treatments targeting those identified exactly becomes standard fare within a few years (even if there probably is a bunch of cancerous mutations the number should be somewhat restricted considering much of the risks are hereditary).